Daxor Income from Discontinued Operations 2010-2011 | DXR

Daxor income from discontinued operations from 2010 to 2011. Income from discontinued operations can be defined as income or loss from the complete discontinuation of a segment or business, net of associated taxes and fees.
Daxor Annual Income from Discontinued Operations
(Millions of US $)
2011 $
2010 $
2009 $
Daxor Quarterly Income from Discontinued Operations
(Millions of US $)
2011-12-31
2011-09-30
2011-06-30
2011-03-31
2010-12-31
2010-09-30
2010-06-30
2010-03-31
2009-12-31
2009-09-30
2009-06-30
2009-03-31
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.044B $0.000B
Daxor Corporation is a medical device manufacturing corporation with additional biotech services.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $21.223B 12.84
Quest Diagnostics (DGX) United States $17.268B 17.71
DaVita (DVA) United States $13.687B 16.84
Encompass Health (EHC) United States $9.264B 22.79
Chemed (CHE) United States $8.808B 27.08
Elanco Animal Health (ELAN) United States $7.449B 16.74
Option Care Health (OPCH) United States $5.396B 26.51
RadNet (RDNT) United States $5.150B 122.18
Amedisys (AMED) United States $3.183B 22.77
Astrana Health (ASTH) United States $2.839B 40.17
LifeStance Health (LFST) United States $2.625B 0.00
Addus HomeCare (ADUS) United States $2.408B 29.24
U.S Physical Therapy (USPH) United States $1.282B 34.70
Pennant (PNTG) United States $1.076B 51.61
Aveanna Healthcare Holdings (AVAH) United States $1.063B 0.00
Atai Life Sciences (ATAI) Germany $0.211B 0.00
ATI Physical Therapy (ATIP) United States $0.025B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.019B 0.00
Psychemedics (PMD) United States $0.014B 0.00
Ontrak (OTRK) United States $0.010B 0.00
Novo Integrated Sciences (NVOS) United States $0.006B 0.00
IMAC Holdings (BACK) United States $0.002B 0.00